Dr. Gregory J. McKenna, MD

Dr. McKenna practices at Baylor Scott & White All Saints Medical Center - Fort Worth in Fort Worth, Texas, part of Baylor Scott & White Health.

Dr. McKenna's NPI, 1467489799, was assigned on June 26, 2006. Dr. McKenna graduated from Dalhousie University Faculty of Medicine in 1995. Dr. McKenna holds Texas license M0486.

Dr. McKenna's primary practice is Baylor Scott & White All Saints Medical Center - Fort Worth, at 1400 Eighth Ave, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 926-2544.

Dr. McKenna's primary practice is Baylor Scott & White All Saints Medical Center - Fort Worth in Fort Worth, Texas, part of Baylor Scott & White Health. Dr. McKenna is also affiliated with Baylor University Medical Center. The medical group on file is HealthTexas Provider Network (HTPN). Dmand AI also links Dr. McKenna to 1 more group practice or clinic, 1 home health agency and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McKenna practices, 5 sites in all. Vendor and product names are available with a free account.

Transplant surgery is Dr. McKenna's primary specialty in the NPI Registry, under taxonomy code 204F00000X. Dr. McKenna is board certified in surgery by the American Board of Surgery. Dr. McKenna is licensed in Texas.

Dmand AI lists kidney transplant among the conditions Dr. McKenna treats.

CMS data shows 228 Medicare services from Dr. McKenna across 6 procedure codes in 2024, for 96 Medicare patients. Medicare paid $64,689 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 96 Medicare patients who saw Dr. McKenna in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 20% are also on Medicaid. Their average risk score is 5.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McKenna's median patient age at 63, with 42% women.

In 2024, Dr. McKenna wrote 106 Medicare Part D claims for 32 patients. 96% of them were for generic drugs. CMS names the drug for 63 of them, across 2 drugs with 11 or more claims each, at $5,344 in total drug cost. In 2022, CMS named 41 claims across 3 drugs.

Dr. McKenna accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McKenna as offering telehealth.

Dmand AI links 29 papers to Dr. McKenna, published from 2013 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Tissue and Organ Procurement, Liver Transplantation and Graft Survival. Dr. McKenna has published most often in Am J Transplant. Dr. McKenna's most frequent co-authors are Giuliano Testa, MD, Anji Elizabeth Wall, MD and Richard Martin Ruiz, MD.

CMS Open Payments shows 17 general payments to Dr. McKenna from 9 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 67% of the total. Calliditas Therapeutics US Inc. paid the most, $2,900.

Dmand AI lists 2 awards for Dr. McKenna, most recently Fellow in 2002. Dr. McKenna serves on ASTS.

Dr. McKenna graduated from Dalhousie University Faculty of Medicine in 1995. Dr. McKenna is a member of ACS.

Dr. McKenna is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.